Drug Delivery Across Blood Brain Barrier Market Size Is Expected To Cross USD 4.6 Billion By 2026



San Francisco, 12 March 2020: The Report  Drug Delivery Across Blood Brain Barrier Market Size, Share & Trends Analysis Report By Drug Delivery Technology (Increasing Permeability, Trojan Approach), By Application, And Segment Forecasts, 2019 – 2026

The global drug delivery across blood brain barrier market size is expected to reach USD 4.6 billion by 2026, according to a new report by Grand View Research, Inc. registering a CAGR of 30.2% over the forecast period. Growing research, innovation, and treatment development activities to overcome the challenges faced due to the natural blood brain barrier is majorly driving the market growth.

Growing prevalence of neurological diseases, such as Parkinson’s and Alzheimer’s disease is fueling the demand for novel drug delivery technology that allows medication to cross the blood brain barrier. Limited treatment options regarding blood-brain barrier has been a big hurdle till recently. However, the growing demand for treatment and the rise in innovations that allow for safe and reliable transmission of medication across the BBB is predicted to drive the market’s growth over the forecast period.

Among the recently developed technologies, increasing permeability of the BBB via ultrasound is the most promising one that has shown safe and effective application in treating various patients with brain cancer and other neurogenetical disorders. Other novel technologies such as in-vitro BBB modeling/engineering is being used for producing a faster, reliable, and cost-effective drug delivery mechanism for overcoming the complexities of BBB.
Increasing use of engineered antibiotics are being tested as a technique for delivering cures for severe brain disorders, such as Alzheimer’s and Hunter’s disease. Such antibiotics are expected to greatly increase the convenience of treatment, in addition to the increased effectivity.

Access Research Report of Drug Delivery Across Blood Brain Barrier Market @ https://www.grandviewresearch.com/industry-analysis/drug-delivery-across-blood-brain-barrier-market

Further Key Findings from the Report Suggest:
  • Based on the drug delivery technology, increasing permeability of BBB segment registered significant share of the drug delivery across blood brain barrier market owing to successful ultrasound device technology that have been deemed effective in providing therapies for treating brain disorders
  • Trojan horse approach segment is expected to lead the market soon, since engineered antibodies have been observed to provide reliable and safe medical treatment for various cancer, immunity, and genetic disorder’s treatment
  • Based on application, Parkinson’s disorder segment held maximum share in the market in 2018 owing to increased incidences of the targeted disorder among the growing geriatric population worldwide. Many major economies in EU and Asia are expected to significantly observe a growth in geriatric population by 2050.
  • Asia Pacific is anticipated to lead this market over the forecast period owing to rising geriatric population that may be prone to brain disorders and opportunity for the industry players due to medical tourism in the region. However, by revenue, North America shall continue to be the largest market due to the high cost of healthcare treatment.
  • Some of the players profiled in drug delivery across blood brain barrier market include Ossianix, Inc., Insightec, Angiochem Inc., Armagen Technologies, Inc., BrainsGate, BiOasis Technologies, Inc., CarThera, F. Hoffman La-Roche, and Iproteos S.L.
Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global drug delivery across blood brain barrier market based on drug delivery technology, application, and region:
Drug Delivery Across Blood Brain Barrier Drug Delivery Technology Outlook (Revenue, USD Million, 2016 - 2026)
  • Trojan Horse Approach
  • Bispecific Antibody RMT Approach
  • Increasing the Permeability of BBB
  • Passive Diffusion
  • Other Non-Invasive BBB Technologies
Drug Delivery Across Blood Brain Barrier Application Outlook (Revenue, USD Million, 2016 - 2026)
  • Alzheimer’s Disease
  • Epilepsy
  • Parkinson’s Disease
  • Multiple Sclerosis
  • Hunter’s Syndrome
  • Brain Cancer
  • Others
Drug Delivery Across Blood Brain Barrier Regional Outlook (Revenue, USD Million, 2016 - 2026)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Access Press Release of Drug Delivery Across Blood Brain Barrier Market @ https://www.grandviewresearch.com/press-release/global-drug-delivery-across-blood-brain-barrier-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Asia Pacific PoC Diagnostics Market Growth Opportunities, Industry Analysis And Forecast: Grand View Research Inc.

Image
San Francisco, 18 March 2020 :  The Report   Asia Pacific PoC Diagnostics Market  Analysis And Segment Forecasts To 2020 The Asia Pacific point of care (PoC) diagnostics market is expected to reach USD 5,427.1 million by 2020, according to a new study by Grand View Research, Inc. Growing base of geriatric population and the ability to render immediate results and improve patient care coupled with rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) are expected to drive demand over the next six years. Skilled staff shortages, especially pertaining to the field of diagnostics are also expected to accelerate the market penetration rates of PoC products, by expediting lab automation processes. Rising demand for home healthcare and other healthcare establishments catering to the elderly population and initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models are also expect
Read more

Food Additives Market Size & Share Hit USD 55.53 Billion By 2022 : Grand View Research Inc.

Image
San Francisco, 17 October 2019:   The Report   Global Food Additives Market   Analysis By Product Flavors & Enhancers (Natural, Artificial), Sweeteners (High Intensity, HFCS), Enzymes, Emulsifiers (Mono, Di-Glycerides, Lecithin, Stearoyl Lactylates, Sorbitan Esters), Shelf-life Stabilizers, Fat Replacers (Protein, Starch)] And Segment Forecast To 2022 Global food additives market is expected to reach USD 55.53 billion by 2022, according to a new study by Grand View Research, Inc. Food & beverage industry growth in BRICS and Middle East on account of rising domestic consumption and increasing foreign direct investments is expected to augment market growth. Asia Pacific is expected to be one of the most promising markets on account of growing domestic consumption in China and India owing to population growth and new product launches by food & beverage manufacturers. Availability of raw materials such as sorbitol and lactic acid in China, Indonesia, and Malaysia in light o
Read more

Integration Platform as a Service Market Valuation Is Expected To Exceed USD 2.70 Billion By 2025: Grand View Research Inc.

Image
San Francisco, 18 March 2020 :  The Report   Integration Platform as a Service (IPaaS) Market  Analysis By Integration Type (API, Process, Application, Data), By Services, By Deployment (Cloud, On-Premise, Hybrid) By Region, And Segment Forecasts, 2018 – 2025 The global integration platform as a service (IPaaS) market is expected to reach USD 2.705.8 million by 2025, according to a new report by Grand View Research, Inc. Rising need of advanced systems to improve the process of deploying, developing, and managing enterprise applications globally has been a major factor driving market growth. In addition, recent developments in big data, cloud computing, and Internet of Things (IoT) within organizations’ processes also paved the way for greater development of IPaaS solutions. Integration Platform as a Service is an emerging technology where in the applications, process, data, and application programs are integrated. The integration enables enterprises to reduce the complexity
Read more